ECSP10010721A - Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida - Google Patents
Nifurtimox para el tratamiento de enfermedades causadas por trichomonadidaInfo
- Publication number
- ECSP10010721A ECSP10010721A EC2010010721A ECSP10010721A ECSP10010721A EC SP10010721 A ECSP10010721 A EC SP10010721A EC 2010010721 A EC2010010721 A EC 2010010721A EC SP10010721 A ECSP10010721 A EC SP10010721A EC SP10010721 A ECSP10010721 A EC SP10010721A
- Authority
- EC
- Ecuador
- Prior art keywords
- nifurtimox
- treatment
- diseases caused
- trichomonadida
- histomoniasis
- Prior art date
Links
- ARFHIAQFJWUCFH-IZZDOVSWSA-N Nifurtimox Chemical compound CC1CS(=O)(=O)CCN1\N=C\C1=CC=C([N+]([O-])=O)O1 ARFHIAQFJWUCFH-IZZDOVSWSA-N 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229960002644 nifurtimox Drugs 0.000 title abstract 2
- 241001502500 Trichomonadida Species 0.000 title 1
- 241000286209 Phasianidae Species 0.000 abstract 1
- 208000010362 Protozoan Infections Diseases 0.000 abstract 1
- 241000224526 Trichomonas Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere al uso de nifurtimox para el tratamiento de enfermedades causadas por tricomonas, tales como, por ejemplo, la histomoniasis, particularmente en pavos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008031283A DE102008031283A1 (de) | 2008-07-02 | 2008-07-02 | Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP10010721A true ECSP10010721A (es) | 2011-01-31 |
Family
ID=41092164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2010010721A ECSP10010721A (es) | 2008-07-02 | 2010-12-27 | Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8440613B2 (es) |
| EP (1) | EP2310017B1 (es) |
| JP (1) | JP5571659B2 (es) |
| KR (1) | KR20110031360A (es) |
| CN (1) | CN102083440B (es) |
| AR (1) | AR072426A1 (es) |
| AU (1) | AU2009266124B2 (es) |
| CA (1) | CA2729727A1 (es) |
| CL (1) | CL2010001594A1 (es) |
| CO (1) | CO6321268A2 (es) |
| CR (1) | CR20110023A (es) |
| DE (1) | DE102008031283A1 (es) |
| DK (1) | DK2310017T3 (es) |
| DO (1) | DOP2010000406A (es) |
| EC (1) | ECSP10010721A (es) |
| ES (1) | ES2415231T3 (es) |
| IL (1) | IL209999A0 (es) |
| MX (1) | MX2010014444A (es) |
| NI (1) | NI201100009A (es) |
| PE (1) | PE20110370A1 (es) |
| PL (1) | PL2310017T3 (es) |
| RU (1) | RU2538712C2 (es) |
| SV (1) | SV2011003784A (es) |
| UA (1) | UA103197C2 (es) |
| WO (1) | WO2010000398A1 (es) |
| ZA (1) | ZA201009226B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2633855A1 (en) | 2012-03-01 | 2013-09-04 | Veterinärmedizinische Universität Wien | Protease inhibitors for treating Trichomonas gallinae infections |
| RS62130B1 (sr) | 2015-05-20 | 2021-08-31 | Boehringer Ingelheim Animal Health Usa Inc | Antihelmintička depsipeptidna jedinjenja |
| EP3397638B1 (en) | 2015-12-28 | 2023-08-23 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic depsipeptide compounds |
| JP6085706B1 (ja) * | 2016-03-31 | 2017-02-22 | 株式会社ポーラファルマ | 抗トリトリコモナス剤 |
| BR112019009977A2 (pt) | 2016-11-16 | 2019-08-27 | Boehringer Ingelheim Animal Health Usa Inc | compostos depsipeptídicos anti-helmínticos |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1170957B (de) | 1962-11-23 | 1964-05-27 | Bayer Ag | Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten |
| NO176766C (no) * | 1989-02-07 | 1995-05-24 | Meiji Seika Kaisha | Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet |
| DK0634408T3 (da) | 1992-03-17 | 2002-04-22 | Fujisawa Pharmaceutical Co | Depsipeptidderivater, fremstilling og anvendelse deraf |
| DE4317458A1 (de) | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
| CN1073560C (zh) | 1993-02-19 | 2001-10-24 | 明治制果株式会社 | 环缩酚酸肽pf1022衍生物 |
| DE4317432A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
| DE4317457A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
| EP0718293B1 (en) | 1993-09-06 | 2002-03-13 | Fujisawa Pharmaceutical Co., Ltd. | Cyclodepsipeptide compound |
| DE4401389A1 (de) | 1994-01-19 | 1995-07-20 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung |
| DE4406025A1 (de) | 1994-02-24 | 1995-08-31 | Bayer Ag | Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung |
| DE4437198A1 (de) | 1994-10-18 | 1996-04-25 | Bayer Ag | Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden |
| EP0872481B1 (en) | 1995-06-30 | 2009-03-18 | Astellas Pharma Inc. | Depsipeptide derivative, process for production thereof, and novel intermediate therefor |
| DE69634961T2 (de) | 1995-09-22 | 2006-04-20 | Bayer Ag | Neue zyklische depsipeptid pf1022 derivate |
| DE19545639A1 (de) | 1995-12-07 | 1997-06-12 | Bayer Ag | Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen |
| US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| UA5478U (uk) * | 2004-06-21 | 2005-03-15 | Ігор Едуардович Лук'янов | Спосіб лікування хворих на урогенітальний трихомоніаз |
| WO2006053160A2 (en) * | 2004-11-12 | 2006-05-18 | Celgene Corporation | Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
-
2008
- 2008-07-02 DE DE102008031283A patent/DE102008031283A1/de not_active Withdrawn
-
2009
- 2009-06-20 WO PCT/EP2009/004474 patent/WO2010000398A1/de not_active Ceased
- 2009-06-20 AU AU2009266124A patent/AU2009266124B2/en not_active Ceased
- 2009-06-20 CN CN2009801255062A patent/CN102083440B/zh not_active Expired - Fee Related
- 2009-06-20 MX MX2010014444A patent/MX2010014444A/es active IP Right Grant
- 2009-06-20 KR KR1020117002465A patent/KR20110031360A/ko not_active Withdrawn
- 2009-06-20 EP EP09772098.1A patent/EP2310017B1/de not_active Not-in-force
- 2009-06-20 CA CA2729727A patent/CA2729727A1/en not_active Abandoned
- 2009-06-20 ES ES09772098T patent/ES2415231T3/es active Active
- 2009-06-20 PL PL09772098T patent/PL2310017T3/pl unknown
- 2009-06-20 UA UAA201101129A patent/UA103197C2/uk unknown
- 2009-06-20 PE PE2010001202A patent/PE20110370A1/es not_active Application Discontinuation
- 2009-06-20 DK DK09772098.1T patent/DK2310017T3/da active
- 2009-06-20 JP JP2011515178A patent/JP5571659B2/ja not_active Expired - Fee Related
- 2009-06-20 RU RU2011103476/15A patent/RU2538712C2/ru not_active IP Right Cessation
- 2009-06-20 US US13/000,871 patent/US8440613B2/en not_active Expired - Fee Related
- 2009-06-30 AR ARP090102440A patent/AR072426A1/es not_active Application Discontinuation
-
2010
- 2010-12-15 IL IL209999A patent/IL209999A0/en unknown
- 2010-12-22 ZA ZA2010/09226A patent/ZA201009226B/en unknown
- 2010-12-27 EC EC2010010721A patent/ECSP10010721A/es unknown
- 2010-12-27 CO CO10162853A patent/CO6321268A2/es not_active Application Discontinuation
- 2010-12-27 DO DO2010000406A patent/DOP2010000406A/es unknown
- 2010-12-28 CL CL2010001594A patent/CL2010001594A1/es unknown
-
2011
- 2011-01-03 SV SV2011003784A patent/SV2011003784A/es unknown
- 2011-01-05 NI NI201100009A patent/NI201100009A/es unknown
- 2011-01-11 CR CR20110023A patent/CR20110023A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO6321268A2 (es) | 2011-09-20 |
| JP5571659B2 (ja) | 2014-08-13 |
| SV2011003784A (es) | 2011-05-20 |
| ES2415231T3 (es) | 2013-07-24 |
| EP2310017A1 (de) | 2011-04-20 |
| EP2310017B1 (de) | 2013-05-15 |
| ZA201009226B (en) | 2012-03-23 |
| DE102008031283A1 (de) | 2010-01-07 |
| UA103197C2 (uk) | 2013-09-25 |
| AU2009266124B2 (en) | 2015-03-19 |
| WO2010000398A1 (de) | 2010-01-07 |
| US8440613B2 (en) | 2013-05-14 |
| CL2010001594A1 (es) | 2011-05-06 |
| IL209999A0 (en) | 2011-02-28 |
| AU2009266124A1 (en) | 2010-01-07 |
| PE20110370A1 (es) | 2011-06-22 |
| CA2729727A1 (en) | 2010-01-07 |
| DOP2010000406A (es) | 2011-01-15 |
| NI201100009A (es) | 2011-08-10 |
| RU2011103476A (ru) | 2012-08-10 |
| DK2310017T3 (da) | 2013-07-01 |
| MX2010014444A (es) | 2011-02-22 |
| PL2310017T3 (pl) | 2013-08-30 |
| CN102083440A (zh) | 2011-06-01 |
| US20110118176A1 (en) | 2011-05-19 |
| CR20110023A (es) | 2011-05-10 |
| JP2011526264A (ja) | 2011-10-06 |
| KR20110031360A (ko) | 2011-03-25 |
| CN102083440B (zh) | 2013-03-27 |
| RU2538712C2 (ru) | 2015-01-10 |
| AR072426A1 (es) | 2010-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016001733A1 (es) | Compuestos intermediarios para la preparación de compuestos derivados de piperidinona como inhibidores mdm2 para el tratamiento de cáncer div. sol. 3415-12. | |
| DOP2014000093A (es) | Compuestos con actividad nematicida | |
| CR20140161A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
| MX2019003738A (es) | Compuestos antivirales. | |
| CO6771447A2 (es) | Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina | |
| ECSP14017269A (es) | Compuestos para tratar la atrofia muscular espinal | |
| CR20150296A (es) | Novedosos derivados de bencimidazol como antagonistas de ep4 | |
| GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
| CR20140183A (es) | Compuestos con actividad nematicida | |
| CO6640285A2 (es) | 5-alquinil-pirimidinas | |
| UY34657A (es) | ?derivados macrocíclicos para el tratamiento de enfermedades?. | |
| UY33396A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
| CU20140048A7 (es) | Novedosos derivados de purina útiles en el tratamiento del cáncer y trastornos neurodegenerativos | |
| SV2010003662A (es) | Derivados de azetidina y ciclobutano como inhibidores de jak ref. x-19081 | |
| UY33627A (es) | Compuestos para tratar enfermedades neurodegenerativas | |
| CL2012003681A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica; y su uso como inhibidores de acetil-coa carboxilasa para el tratamiento de trastornos metabolicos, tales como obesidad y diabetes. | |
| GEP201706710B (en) | Imidazopyridazine derivatives as gabaa receptor modulators | |
| CO6341625A2 (es) | Derivados de indol como agentes anticáncer | |
| UY34612A (es) | ?procedimiento para la preparación de derivados de isoxazolina azetidina quirales como agentes antiparasitarios?. | |
| DOP2014000114A (es) | Nuevos 2hindazoles como antagonistas del receptor ep2 | |
| UY34407A (es) | Nuevos moduladores de trpv3 | |
| CR20110023A (es) | Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida | |
| BR112012019920A2 (pt) | derivados de piridazina úteis como agonístas de canabinoide-2. | |
| MX2013001612A (es) | Moduladores de trpv3 novedosos. | |
| DOP2015000007A (es) | Métodos para preparar triazolopiridinas sutituidas |